X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

期刊標題檢索 J CELL MOL MED 最新評論: Why did it go from "under review" to "awaiting eic decision" in just o... (2024-10-20)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[JOURNAL OF CELLULAR AND MOLECULAR MEDICINE]您好,您是該頁面的第 17092 位訪客。

期刊簡介
期刊名稱JOURNAL OF CELLULAR AND MOLECULAR MEDICINE JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LetPub Score
7.1
50 ratings
Rate

Reputation
8.3

Influence
6.1

Speed
7.1

期刊簡稱J CELL MOL MED
ISSN1582-4934
h-indexN.A.
CiteScore
CiteScoreSJRSNIPCiteScore Rank
11.501.2070.917
Subject fieldQuartilesRankPercentile
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Molecular Medicine
Q127 / 178
Category: Biochemistry, Genetics and Molecular Biology
Subcategory: Cell Biology
Q146 / 285

自引率 (2023-2024)0.00%自引率趨勢
掲載範囲
Bridging physiology and cellular medicine, and molecular biology and molecular therapeutics, Journal of Cellular and Molecular Medicine publishes basic research that furthers our understanding of the cellular and molecular mechanisms of disease and translational studies that convert this knowledge into therapeutic approaches.
官方網站https://onlinelibrary.wiley.com/journal/15824934
在線稿件提交https://mc.manuscriptcentral.com/jcmm
開放訪問Yes
出版商Wiley-Blackwell
主題領域Biochemistry, Genetics and Molecular Biology
出版國/地區United Kingdom
發行頻率
創刊年0
每年文章數403每年文章數趨勢
黃金OA百分比65.76%
OA Related Info
APC: Yes( USD4510; GBP2920; EUR4180; )
APC waiver:Check Notes
Other charges: No
Keywords: cellular medicine、molecular medicine
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardPeer review
Web of Science 四分位
2023-2024
WOS Quartile: Q2

CategoryEditionJIF QuartileJIF RankingJIF Percentage
CELL BIOLOGYSCIEQ281/205
MEDICINE, RESEARCH & EXPERIMENTALSCIEQ258/189
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1582-4934%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 28 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【JOURNAL OF CELLULAR AND MOLECULAR MEDICINE】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    Journal for ImmunoTherapy of CancerH-index: 36

    CiteScore: 17.70
    Biomarker ResearchH-index: 0

    CiteScore: 15.80
    Cell Chemical BiologyH-index: 166

    CiteScore: 14.70
    Molecular BiomedicineH-index: 0

    CiteScore: 6.30
    Molecular OncologyH-index: 63

    CiteScore: 12.60
    VIROLOGICA SINICAH-index: 20

    CiteScore: 9.30
    Biotechnology JournalH-index: 70

    CiteScore: 8.90
    Frontiers in GeneticsH-index: 61

    CiteScore: 5.50
    Pharmacogenomics & Personalized MedicineH-index: 0

    CiteScore: 3.30
    Advances in Biological RegulationH-index: 0

    CiteScore: 8.90
    學科內最受檢索的期刊 頁面查看次數
    Frontiers in Genetics334768
    Cell Chemical Biology78305
    Journal for ImmunoTherapy of Cancer77342
    Biotechnology Journal44195
    VIROLOGICA SINICA41051
    Biomarker Research37509
    Molecular Oncology32756
    Pharmacogenomics & Personalized Medicine15172
    Molecular Biomedicine7109
    Exploration of Medicine4119
  •  

    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/49)
  [JOURNAL OF CELLULAR AND MOLECULAR MEDICINE] 的評論撰寫評論
作者: 岱宗康平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-20 19:27:39 評論於
Why did it go from "under review" to "awaiting eic decision" in just one day?
(0) 讚! | 岱宗康平

作者: 岱宗康平


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-20 18:01:50 評論於
Why did my status go from "under review" to "awaiting EIC decision" in just one day?
(0) 讚! | 岱宗康平

作者: 岭南艳兵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-20 11:35:57 評論於
May I ask if you have accepted it?
(0) 讚! | 岭南艳兵

作者: 桃花曼衍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-13 21:48:33 評論於
It's been two months, I'm ready to leave, it's too outrageous.
(0) 讚! | 桃花曼衍

作者: 桃花曼衍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-13 19:05:07 評論於
It has been two months since "Awaiting Admin Processing", I feel like the editor has forgotten about me. I have sent two letters urging for a response but have received no reply.
(0) 讚! | 桃花曼衍

作者: 京城惠丽


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-12 10:09:54 評論於
How long has the status of "Awaiting EIC Decision" been ongoing for?
(0) 讚! | 京城惠丽

作者: 耶塔内尔


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-05 09:28:01 評論於
Submission success rate: 25.0
Experience sharing: Does this magazine have two ADMs? Does UR represent internal or external editorial review?
(0) 讚! | 耶塔内尔

作者: 终幕兰若


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-26 21:54:51 評論於
It has been 8 months since my second submission from the initial submission.
(0) 讚! | 终幕兰若

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-21 21:03:38 評論於
What is the current status now? Has it changed?
(0) 讚! | Adelaide Lawson

作者: 桃花曼衍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-21 21:03:22 評論於
I'm going crazy, if the other group is not satisfied with this submission, they will reject it immediately. I haven't been assigned as the chief editor for this month yet.
(0) 讚! | 桃花曼衍

作者: 岭南艳兵


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-21 12:08:17 評論於
I have been waiting for five months for the first review and still have not received any result. ?
(0) 讚! | 岭南艳兵

作者: 桃花曼衍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-21 09:58:16 評論於
I have sent reminder emails to urge for submission, but the editorial department has not responded.
(0) 讚! | 桃花曼衍

作者: 中原怀瑶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-20 15:11:22 評論於
Do you want to write a letter to remind them?
(0) 讚! | 中原怀瑶

作者: 中原怀瑶


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-20 08:08:32 評論於
How is it going now? Mine has been "Awaiting Admin Processing" for a month as well.
(0) 讚! | 中原怀瑶

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-18 14:36:27 評論於
You can inquire with the editorial department via email, the average review period for this journal is about three months. It has been over a month in your case, so you can ask for an update.
(0) 讚! | Adelaide Lawson

作者: 神古昆雄


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-11 20:17:38 評論於
It's so slow, it's been almost three weeks and it's still in the hands of the editor.
(0) 讚! | 神古昆雄

作者: 桃花曼衍


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-09 10:59:33 評論於
Research focus: Tumor markers; experience sharing on integrating theory with practice: "Awaiting Admin Processing" has been ongoing for a month, what's going on?
(0) 讚! | 桃花曼衍

作者: 金刚迎珊


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-30 16:33:38 評論於
No, just that many.
(0) 讚! | 金刚迎珊

作者: soft


領域: 生物学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-07-06 10:18:30 評論於
Do you have WB experiment? Have you uploaded the uncut film?
(0) 讚! | soft

作者: 北陆亚捷


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-28 13:15:38 評論於
How are you, dear?
(0) 讚! | 北陆亚捷

作者: Mignon Hobbes


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-26 17:19:29 評論於
Review speed: 2.0 Emphasis on research direction: Bone metabolism Experience sharing: How long does it generally take to get results after revisions are submitted, with the first review taking around 40 days?
(0) 讚! | Mignon Hobbes

作者: 魔都树茂


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-06-15 22:41:37 評論於
Review speed: 12.0 | Submission hit rate: 50.0
Research focus: Tumor; Validation experience sharing: I would like to share my submission timeline with everyone (to be updated later): Submitted on Jan-13-2024, about two weeks to send out for external review UR has been ongoing until now on June-18-2024. From UR status to Awaiting EIC Decision. I hope it will be accepted later, and will continue to update the status.
(0) 讚! | 魔都树茂

作者: dufanpan


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-05-30 16:09:18 評論於
Submitted on February 9, 2024, the manuscript was sent for external review by the editor after about a week. The external review took about half a month, with major revisions requested on March 4. Two months were given for revisions, and the revised manuscript was resubmitted on May 2. It entered the review process on May 3, awaiting the editor's recommendation on May 22, and the editor-in-chief's decision on May 27. The manuscript was accepted on May 28 (accepted on the same day as the peer defense, sharing the joy).

The journal editor provided insightful comments and the review process was detailed with many targeted suggestions. Each reviewer's comment was addressed in the revisions, resulting in a successful acceptance of the paper. Congratulations to everyone whose articles were accepted!
(0) 讚! | dufanpan

作者: Duncan Sharp


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-23 21:19:48 評論於
I also submitted in November and they have been saying they are still looking for reviewers, so I haven't received any feedback yet
(0) 讚! | Duncan Sharp

作者: 仙灵半菡


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-05-13 17:19:14 評論於
After receiving the article, in addition to the $4510 APC, are there any color charges?
(0) 讚! | 仙灵半菡

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/49)

開始撰寫 [JOURNAL OF CELLULAR AND MOLECULAR MEDICINE] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*